Next-Generation Drug Delivery: RNA Therapeutics and Nanomedicine - Prof. Ernst Wagner
By: Gayatri Srinivas
Conference Manager, InnoPharm 2026
02/09/2026
Prof. Ernst Wagner to Deliver Virtual Keynote Session at InnoPharm-2026.
InnoPharm-2026 is honored to host Prof. Ernst Wagner, Chair of Pharmaceutical Biotechnology at Ludwig-Maximilians-Universität München, as a Virtual Keynote Speaker.
A pioneer in gene delivery and nanomedicine, Prof. Wagner’s work focuses on the development of advanced delivery systems for nucleic acid-based therapeutics, including RNA and DNA. His research has significantly contributed to overcoming one of the biggest challenges in modern therapeutics: delivering drugs precisely and effectively to target cells.
By designing innovative carriers and delivery platforms, Prof. Wagner has enabled new possibilities in gene therapy, cancer treatment, and RNA-based medicines.
Why It Matters:
Efficient drug delivery is critical to the success of next-generation therapeutics. Prof. Wagner’s innovations are helping to unlock the full potential of RNA therapies and nanomedicine, paving the way for more targeted and effective treatments.
About Prof. Wagner:
- Chair, Pharmaceutical Biotechnology, LMU Munich
- Leader in gene delivery and nanomedicine
- Pioneer in RNA therapeutics
- Innovator in targeted drug delivery systems